Journal Article Summary
The article investigates a new nasal formulation combining loratadine and sulpiride in a nanoemulsion to treat allergic rhinitis, a condition characterized by inflammation of the nasal mucosa due to allergens. Allergic rhinitis can significantly impact a person's quality of life, causing symptoms like sneezing, nasal congestion, and itching. Current treatments often do not fully address all symptoms, which highlights the need for more effective therapies. The study aims to explore whether this novel formulation can improve symptom management by targeting inflammatory markers associated with the condition.
In this study, researchers developed a co-loaded nanoemulsion using loratadine and sulpiride and tested its effectiveness in rabbit models induced with allergic rhinitis. The formulation was characterized for its physical properties, including droplet size and stability, and showed high entrapment efficiency for both drugs. The biological effectiveness was evaluated by measuring levels of inflammatory markers TNF-α, TGF-β, and IL-1 before and after treatment. Results indicated that the nanoemulsion significantly reduced the expression of these markers, suggesting a potent anti-inflammatory effect compared to other formulations.
Despite promising results, the study has limitations, including its reliance on animal models, which may not fully replicate human responses. Additionally, the safety and efficacy of this formulation in humans have yet to be established. Patients interested in new treatment options for allergic rhinitis should consult their healthcare providers to discuss potential benefits and risks, as well as to explore existing therapies that may be appropriate for their specific condition.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Mohamad Soad A., Safwat Mohamed A., Elrehany Mahmoud, Maher Sherif A., Badawi Ahmed M., Mansour Heba F.. A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis. Drug Delivery 2021. DOI: 10.1080/10717544.2021.1872741. PMID: 33501873. PMCID: PMC7850330.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
